Correction: Cheaper EpiPen Rival story

TRENTON, N.J. (AP) — In a narrative Dec. 6 a couple of new various to EpiPen, The Related Press reported erroneously that emergency allergy injector Auvi-Q was amongst merchandise that had shortages due to an EpiPen scarcity. Auvi-Q didn’t have shortages.

A corrected model of the story is under:

Generic drugmaker to promote various to EpiPen injectors

Generic drugmaker Sandoz to promote prefilled syringe various to EpiPen emergency allergy medicine


AP Medical Author

TRENTON, N.J. (AP) — Generic drugmaker Sandoz introduced plans Thursday to begin promoting a substitute for the EpiPen within the U.S. early subsequent 12 months.

The EpiPen injector is used to halt life-threatening allergic reactions to insect bites, nuts and different meals. Model-name EpiPen, which dominates the market, has been in brief provide since spring due to manufacturing issues.

Sandoz will promote prefilled syringes with the identical drugs, the hormone epinephrine, underneath the title Symjepi. The worth will probably be $250 for 2, with out insurance coverage.

Two generic variations of EpiPen are bought within the U.S. for $300 a pair, together with one from EpiPen vendor Mylan. The corporate began promoting its personal generic after it was blasted for repeated hikes that pushed up its record value from $94 to $608 for a pair of brand-name EpiPens.

What folks pay varies, although, relying on insurance coverage, reductions and the pharmacy.

Mylan’s injectors are made by a subsidiary of Pfizer, which is upgrading factories to repair high quality issues. That resulted in manufacturing slowdowns. Pfizer mentioned Thursday it is transport some injectors and expects to ship extra within the coming months.

The shortages triggered non permanent shortages of other merchandise. Consequently, U.S. regulators let some producers lengthen expiration dates.

Sandoz, a part of Novartis AG, will promote syringes with an grownup dose made by Adamis Prescription drugs Corp. A kids’s model will observe.

Israel’s Teva Pharmaceutical Industries started promoting restricted portions of its new generic EpiPen within the U.S. final week.


Comply with Linda A. Johnson on Twitter: @LindaJ_onPharma


The Related Press Well being & Science Division receives assist from the Howard Hughes Medical Institute’s Division of Science Training. The AP is solely answerable for all content material.

Show More

Leave a Reply